Andrew Blauvelt
Adjunct Professor · Univ of Maryland Sch of Med
Credentials: · · ·
History
Present- Present
- 1989–1992
- 1988–1989
Preliminary or Transitional Year
Research
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
New England Journal of Medicine · 2016 · 1,611 citations
The Lancet · 2017 · First of 31 authors · Corresponding · 980 citations
Journal of the American Academy of Dermatology · 2017 · First of 8 authors · Corresponding · 697 citations
61 papers
54 papers
51 papers
34 papers
24 papers
23 papers
- CL
23 papers
23 papers
Grants
- 2007–2009
Role of Il-23 in Psoriasis Pathogenesis
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $331.4K · Oregon Health & Science University
The Role of Kaposi's Sarcoma-Associated Herpesvirus in t
National Cancer Institute · Z01
Contact PI · Division of Clinical Sciences - Nci
Langerhans Cells in Immunopathogenesis of HIV Disease
National Cancer Institute · Z01
Contact PI · Division of Clinical Sciences - Nci
Novel Translational Studies for Psoriasis
National Cancer Institute · Z01
Contact PI · Division of Clinical Sciences - Nci
Clinical trials
- 2014
Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
Principal investigator · Completed · Phase 2
Aclaris Therapeutics, Inc.